Lipella Pharmaceuticals Inc. Common Stock (LIPO) — Strategic Asset Allocation Index
Lipella Pharmaceuticals Inc. Common Stock (LIPO) has a Strategic Asset Allocation Index of 3.2% as of December 2022. Strategic assets (PP&E of $150.82K plus long-term investments of $-) total $150.82K, measured against net assets of $4.68 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See net asset quality index of Lipella Pharmaceuticals Inc. Common Stoc to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Lipella Pharmaceuticals Inc. Common Stock Strategic Asset Allocation Index (2020–2022)
This chart shows how Lipella Pharmaceuticals Inc. Common Stock's Strategic Asset Allocation Index has evolved across 3 annual periods from 2020 to 2022. As of December 2022, the index stands at 3.2%, representing strategic assets of $150.82K against net assets of $4.68 Million USD. For live market cap and overall valuation, see LIPO company net worth.
Annual Strategic Asset Allocation Index for Lipella Pharmaceuticals Inc. Common Stock (2020–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Lipella Pharmaceuticals Inc. Common Stock from 2020 to 2022, covering 3 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See net assets of Lipella Pharmaceuticals Inc. Common Stoc for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 3.2% | $150.82K | $150.82K | $- | $4.68 Million | ▼ -11.2 pp |
| 2021 | 14.4% | $204.80K | $204.80K | $- | $1.42 Million | ▼ -40.8 pp |
| 2020 | 55.2% | $255.59K | $255.59K | $- | $463.32K | — |